Origin Pharma Packaging Launch New Child Resistant Jar
Child Resistant Jar for Medicinal Cannabis
Origin Pharma Packaging has launched a piece of packaging dedicated to the medicinal cannabis industry
The newly designed child-resistant jar is created to support the ‘flower product which is often prescribed in certain European countries as ‘buds’.
Origin Pharma Packaging has launched a piece of packaging dedicated to the medicinal cannabis industry
The newly designed child-resistant jar is created to support the ‘flower# product which is often prescribed in certain European countries as ‘buds’. These products/ medicines have to be packaged up safely as they will be entering a domestic environment where children may be present.
Origin has created a packaging team for 2020, to enable and support start-up medicinal cannabis companies who do not have the capacity or resources to have their own packaging, development and supply chain team.
The jar is manufactured in Origin’s cleanroom manufacturing facility based in Welton, Yorkshire (UK). The packaging development team is developing a number of packaging pieces which is supporting this ground-breaking and exciting industry.
Get a free sample of our child-resistant jar here: Click here for a free sample
To find out more about Origin’s medicinal packaging team, head to: https://www.originltd.com/packaging-design/medicinal-cannabis-packaging/
Related News
-
Sponsored Content CPHI Online Trend Report: How can flow chemistry help businesses achieve their sustainability goals?
In our latest CPHI Online Trend Report, we partner with Asymchem to understand the innovative potential of flow chemistry for API manufacturing, especially in regards to meeting sustainability goals.
-
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
Sponsored Content Discover Our Organic Mineral Salts as APIs
Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®.
-
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec.
-
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
Sponsored Content Pharma Trend Outlook: Pharma 4.0 and Industry Resilience
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.
-
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am...